4.08
price down icon2.39%   -0.10
pre-market  プレマーケット:  4.16   0.08   +1.96%
loading
前日終値:
$4.18
開ける:
$4.2
24時間の取引高:
2.38M
Relative Volume:
0.37
時価総額:
$888.23M
収益:
$76.20M
当期純損益:
$-17.37M
株価収益率:
448.35
EPS:
0.0091
ネットキャッシュフロー:
$-75.81M
1週間 パフォーマンス:
-0.97%
1か月 パフォーマンス:
-10.53%
6か月 パフォーマンス:
-3.09%
1年 パフォーマンス:
+324.47%
1日の値動き範囲:
Value
$4.04
$4.255
1週間の範囲:
Value
$3.99
$4.38
52週間の値動き範囲:
Value
$0.9041
$8.21

Cytomx Therapeutics Inc Stock (CTMX) Company Profile

Name
名前
Cytomx Therapeutics Inc
Name
セクター
Healthcare (1106)
Name
電話
650.515.3185
Name
住所
151 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA
Name
職員
69
Name
Twitter
@cytomxinc
Name
次回の収益日
2026-05-07
Name
最新のSEC提出書
Name
CTMX's Discussions on Twitter

Compare CTMX vs VRTX, REGN, ARGX, ALNY, ONC

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
CTMX icon
CTMX
Cytomx Therapeutics Inc
4.08 888.23M 76.20M -17.37M -75.81M 0.0091
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
424.36 107.87B 12.32B 4.34B 3.19B 16.86
REGN icon
REGN
Regeneron Pharmaceuticals Inc
702.27 73.63B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
794.70 49.42B 4.16B 1.29B 734.26M 19.58
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
301.11 40.20B 3.71B 313.75M 465.38M 2.2571
ONC icon
ONC
Beone Medicines Ltd Adr
297.49 33.06B 5.36B 287.73M 924.18M 2.5229

Cytomx Therapeutics Inc Stock (CTMX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-03-16 アップグレード JP Morgan Neutral → Overweight
2026-01-20 開始されました Guggenheim Buy
2025-09-22 開始されました Cantor Fitzgerald Overweight
2025-09-17 再開されました Barclays Overweight
2025-07-31 開始されました Oppenheimer Outperform
2025-05-15 アップグレード H.C. Wainwright Neutral → Buy
2025-04-14 再開されました Piper Sandler Overweight
2024-05-28 アップグレード Piper Sandler Neutral → Overweight
2024-05-09 アップグレード Wedbush Neutral → Outperform
2024-05-06 アップグレード Jefferies Hold → Buy
2024-04-22 アップグレード JP Morgan Underweight → Neutral
2022-11-14 ダウングレード BMO Capital Markets Outperform → Market Perform
2022-07-07 ダウングレード Jefferies Buy → Hold
2022-07-07 ダウングレード Mizuho Buy → Neutral
2022-07-07 ダウングレード Piper Sandler Overweight → Neutral
2022-07-07 ダウングレード Wedbush Outperform → Neutral
2022-06-24 開始されました BMO Capital Markets Outperform
2022-01-18 アップグレード Barclays Underweight → Overweight
2021-11-15 開始されました BTIG Research Buy
2021-05-28 ダウングレード Barclays Equal Weight → Underweight
2021-03-29 開始されました JP Morgan Overweight
2021-03-23 アップグレード Jefferies Hold → Buy
2020-09-22 ダウングレード Guggenheim Buy → Neutral
2020-06-01 ダウングレード Jefferies Buy → Hold
2020-05-14 繰り返されました H.C. Wainwright Buy
2020-03-24 アップグレード Wedbush Neutral → Outperform
2020-03-04 開始されました Barclays Equal Weight
2019-11-20 開始されました Guggenheim Buy
2019-11-11 ダウングレード Wedbush Outperform → Neutral
2019-06-13 開始されました Mizuho Buy
2019-05-14 開始されました Cantor Fitzgerald Overweight
2019-03-11 開始されました Barclays Overweight
2018-11-26 開始されました Piper Jaffray Overweight
2018-10-15 開始されました Goldman Neutral
2018-09-13 開始されました H.C. Wainwright Buy
2018-06-01 開始されました SunTrust Buy
2018-01-05 開始されました Citigroup Buy
2017-09-08 開始されました Wedbush Outperform
2017-03-27 開始されました H.C. Wainwright Buy
2017-03-02 開始されました Instinet Buy
2017-01-03 ダウングレード Oppenheimer Outperform → Perform
2015-11-02 開始されました Oppenheimer Outperform
すべてを表示

Cytomx Therapeutics Inc (CTMX) 最新ニュース

pulisher
May 05, 2026

MSN Money - MSN

May 05, 2026
pulisher
May 02, 2026

CytomX Therapeutics (CTMX) Expected to Announce Quarterly Earnings on Thursday - MarketBeat

May 02, 2026
pulisher
Apr 30, 2026

Certain Restricted Stock Units of CytomX Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 1-MAY-2026. - marketscreener.com

Apr 30, 2026
pulisher
Apr 30, 2026

170,186,365 Common Stock of CytomX Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 1-MAY-2026. - marketscreener.com

Apr 30, 2026
pulisher
Apr 30, 2026

CytomX (NASDAQ: CTMX) proxy adds share capacity and expands equity plans - Stock Titan

Apr 30, 2026
pulisher
Apr 30, 2026

CytomX Therapeutics to Report First Quarter 2026 Financial Results on May 7, 2026 - Yahoo Finance UK

Apr 30, 2026
pulisher
Apr 30, 2026

CytomX Therapeutics, Inc. (NASDAQ:CTMX) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat

Apr 30, 2026
pulisher
Apr 27, 2026

HC Wainwright & Co. Upgrades CytomX Therapeutics (CTMX) - MSN

Apr 27, 2026
pulisher
Apr 27, 2026

CytomX stock rises 31% in a month: Here's what you should know - MSN

Apr 27, 2026
pulisher
Apr 27, 2026

Cantor Fitzgerald Initiates Coverage of CytomX Therapeutics (CTMX) with Overweight Recommendation - MSN

Apr 27, 2026
pulisher
Apr 26, 2026

CytomX Therapeutics launches $250M public offering - MSN

Apr 26, 2026
pulisher
Apr 25, 2026

Wall Street Zen Downgrades CytomX Therapeutics (NASDAQ:CTMX) to Strong Sell - MarketBeat

Apr 25, 2026
pulisher
Apr 24, 2026

CytomX Therapeutics (NASDAQ:CTMX) Stock Price Crosses Below 50-Day Moving AverageHere's What Happened - MarketBeat

Apr 24, 2026
pulisher
Apr 23, 2026

CytomX Therapeutics prices $250M public offering at $5.30 per share - MSN

Apr 23, 2026
pulisher
Apr 23, 2026

CTMX Stock Price, Quote & Chart | CYTOMX THERAPEUTICS INC (NASDAQ:CTMX) - ChartMill

Apr 23, 2026
pulisher
Apr 22, 2026

CTMX (CytomX Therapeutics Inc.) shares climb over 7 percent despite wider than expected Q4 2025 per share losses.Margin of Safety - Cổng thông tin điện tử tỉnh Tây Ninh

Apr 22, 2026
pulisher
Apr 22, 2026

Small Cap or Megacap: Which Healthcare Stock Is Right for You? - The Motley Fool

Apr 22, 2026
pulisher
Apr 22, 2026

CTMX Forecast, Price Target & Analyst Ratings | CYTOMX THERAPEUTICS INC (NASDAQ:CTMX) - ChartMill

Apr 22, 2026
pulisher
Apr 21, 2026

Analysts bullish on CytomX Therapeutics (CTMX) as CTMX prices $250 million offering - MSN

Apr 21, 2026
pulisher
Apr 20, 2026

CytomX (NASDAQ: CTMX) seeks shareholder OK to double authorized shares to 600M - Stock Titan

Apr 20, 2026
pulisher
Apr 20, 2026

CytomX Therapeutics (CTMX) gains analyst confidence on trial progress - MSN

Apr 20, 2026
pulisher
Apr 20, 2026

HC Wainwright & Co. Maintains CytomX Therapeutics (CTMX) Buy Recommendation - MSN

Apr 20, 2026
pulisher
Apr 19, 2026

CytomX Therapeutics (CTMX) making progress on key metastatic colorectal cancer treatment - MSN

Apr 19, 2026
pulisher
Apr 19, 2026

CytomX Therapeutics Inc Share PriceCTMX, RNS News, Articles, Quotes, & Charts (NASDAQ:CTMX) - Proactive financial news

Apr 19, 2026
pulisher
Apr 18, 2026

CTMX SEC FilingsCytomx Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Apr 18, 2026
pulisher
Apr 18, 2026

Why CTMX Stock Is Soaring 54% Pre-Market Today? - MSN

Apr 18, 2026
pulisher
Apr 16, 2026

Point72 (CTMX) reports 10,864,581 shares, a 5.0% holding in CytomX - Stock Titan

Apr 16, 2026
pulisher
Apr 16, 2026

Traders Buy High Volume of CytomX Therapeutics Put Options (NASDAQ:CTMX) - MarketBeat

Apr 16, 2026
pulisher
Apr 16, 2026

CytomX Therapeutics (NASDAQ:CTMX) Stock Price Up 6.3%Time to Buy? - MarketBeat

Apr 16, 2026
pulisher
Apr 16, 2026

CytomX Therapeutics, Inc. (CTMX) Stock Analysis: Exploring a 199.71% Potential Upside in the Biotech Innovator - DirectorsTalk Interviews

Apr 16, 2026
pulisher
Apr 14, 2026

CytomX Therapeutics, Inc. (CTMX) A Top Healthcare Penny Stock Amid Colorectal Cancer Treatment Progress - Insider Monkey

Apr 14, 2026

Cytomx Therapeutics Inc (CTMX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$28.32
price down icon 0.14%
$50.44
price up icon 0.48%
$95.50
price down icon 3.88%
$139.44
price down icon 0.41%
$147.21
price down icon 0.47%
ONC ONC
$297.49
price up icon 0.12%
大文字化:     |  ボリューム (24 時間):